Cargando…

Review of Urate-Lowering Therapeutics: From the Past to the Future

We reviewed all currently available ULT, as well as any medications in development using following databases: United States Food and Drug Administration (FDA), European Medicines Agency (EMA), Japanese Pharmaceutical and Medical Devices Agency (PMDA), and ClinicalTrials.gov. We identified a total of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jenkins, Christopher, Hwang, Jennifer H., Kopp, Jeffrey B., Winkler, Cheryl A., Cho, Sung Kweon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445164/ https://www.ncbi.nlm.nih.gov/pubmed/36081938 http://dx.doi.org/10.3389/fphar.2022.925219

Ejemplares similares

Discovery of URAT1 SNPs and association between serum uric acid levels and URAT1
por: Cho, Sung Kweon, et al.
Publicado: (2015)

Efficacy of Xanthine Oxidase Inhibitors in Lowering Serum Uric Acid in Chronic Kidney Disease: A Systematic Review and Meta-Analysis
por: Lee, Yoojin, et al.
Publicado: (2022)

Effect of Urate-Lowering Therapy on the Progression of Kidney Function in Patients With Asymptomatic Hyperuricemia: A Systematic Review and Meta-Analysis
por: Zhang, Lin, et al.
Publicado: (2022)

Potential Therapeutic Implications of Caffeic Acid in Cancer Signaling: Past, Present, and Future
por: Alam, Manzar, et al.
Publicado: (2022)

Effectiveness of Urate-Lowering Therapy for Renal Function in Patients With Chronic Kidney Disease: A Meta-Analysis of Randomized Clinical Trials
por: Liang, Xiuping, et al.
Publicado: (2022)

Modeling Alzheimer’s disease: from past to future
por: Saraceno, Claudia, et al.
Publicado: (2013)

The Anti-allergic Cromones: Past, Present, and Future
por: Sinniah, Ajantha, et al.
Publicado: (2017)

Verapamil and Alzheimer’s Disease: Past, Present, and Future
por: Popović, Natalija, et al.
Publicado: (2020)

Protein tyrosine phosphatase non-receptor type 2 as the therapeutic target of atherosclerotic diseases: past, present and future
por: Tang, Xiao-Er, et al.
Publicado: (2023)

Bergenin as a Novel Urate-Lowering Therapeutic Strategy for Hyperuricemia
por: Chen, Mo, et al.
Publicado: (2020)

Metabolic Studies in Brain Slices – Past, Present, and Future
por: Hertz, Leif
Publicado: (2012)

The South African Regulatory System: Past, Present, and Future
por: Keyter, Andrea, et al.
Publicado: (2018)

Variation in serum urate levels in the absence of gout and urate lowering therapy
por: Shaffer, Andrew, et al.
Publicado: (2021)

Olaparib and advanced ovarian cancer: Summary of the past and looking into the future
por: Maiorano, Brigida Anna, et al.
Publicado: (2023)

Extracts of Andrographis paniculata (Burm.f.) Nees Leaves Exert Anti-Gout Effects by Lowering Uric Acid Levels and Reducing Monosodium Urate Crystal-Induced Inflammation
por: Rahmi, Eldiza Puji, et al.
Publicado: (2022)

Physiology of Hyperuricemia and Urate-Lowering Treatments
por: Benn, Caroline L., et al.
Publicado: (2018)

Exploring Carbohydrates for Therapeutics: A Review on Future Directions
por: Wang, Jie, et al.
Publicado: (2021)

Adherence with urate-lowering therapies for the treatment of gout
por: Harrold, Leslie R, et al.
Publicado: (2009)

Urate‐lowering therapy for patients with gout on hemodialysis
por: Alkilany, Reem, et al.
Publicado: (2022)

An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives
por: Ye, Qingmei, et al.
Publicado: (2023)

Factors associated with initiation and persistence of urate-lowering therapy
por: Dehlin, Mats, et al.
Publicado: (2017)

Calcific Aortic Valve Disease-Natural History and Future Therapeutic Strategies
por: Alushi, Brunilda, et al.
Publicado: (2020)

Coevolution of URAT1 and Uricase during Primate Evolution: Implications for Serum Urate Homeostasis and Gout
por: Tan, Philip K., et al.
Publicado: (2016)

Mechanism of high affinity inhibition of the human urate transporter URAT1
por: Tan, Philip K., et al.
Publicado: (2016)

Gout Remission as a Goal of Urate-Lowering Therapy: A Critical Review
por: Tabi-Amponsah, Adwoa Dansoa, et al.
Publicado: (2023)

C5a Regulates IL-1β Production and Leukocyte Recruitment in a Murine Model of Monosodium Urate Crystal-Induced Peritonitis
por: Khameneh, Hanif J., et al.
Publicado: (2017)

(−)-Epicatechin Ameliorates Monosodium Urate-Induced Acute Gouty Arthritis Through Inhibiting NLRP3 Inflammasome and the NF-κB Signaling Pathway
por: Wu, Chenxi, et al.
Publicado: (2022)

OAT10/SLC22A13 Acts as a Renal Urate Re-Absorber: Clinico-Genetic and Functional Analyses With Pharmacological Impacts
por: Toyoda, Yu, et al.
Publicado: (2022)

Depressive Symptoms and the Effectiveness of a Urate‐Lowering Therapy in a Clinical Trial
por: Mrug, Sylvie, et al.
Publicado: (2020)

Dotinurad: a novel selective urate reabsorption inhibitor as a future therapeutic option for hyperuricemia
por: Kuriyama, Satoru
Publicado: (2019)

Effect of Fenofibrate in Combination with Urate Lowering Agents in Patients with Gout
por: Lee, You-Hyun, et al.
Publicado: (2006)

Treatment approaches and adherence to urate-lowering therapy for patients with gout
por: Aung, Thanda, et al.
Publicado: (2017)

Inclisiran: a new generation of lipid-lowering siRNA therapeutic
por: Zhang, Yanzhen, et al.
Publicado: (2023)

Allopurinol Lowers Serum Urate but Does Not Reduce Oxidative Stress in CKD
por: Sun, Mingyao, et al.
Publicado: (2022)

Global bioethics: it’s past and future
por: Macpherson, Cheryl
Publicado: (2022)

The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions
por: Shams, Shahin, et al.
Publicado: (2021)

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
por: Becker, Michael A, et al.
Publicado: (2010)

An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia
por: Bove, Marilisa, et al.
Publicado: (2017)

Interventions to improve uptake of urate-lowering therapy in patients with gout: a systematic review
por: Gill, Iqbal, et al.
Publicado: (2020)

Hyperuricemia, urate-lowering therapy, and kidney outcomes: a systematic review and meta-analysis
por: Sharma, Gaurav, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a0c8ch1jpeh53n2hfhjjrims1c